Antigen of Babesia vole bm1524 and its application

A technology of bm1524 and Babesia, applied in the field of bioengineering, can solve the problems of low sensitivity of antigens and methods

Active Publication Date: 2018-06-19
STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The object of the present invention is to provide a kind of Babesia microti Bm1524 antigen and application thereof, described this Babesia microti Bm1524 antigen and application thereof solve the antigen and method sensitivity of diagnosis Babesia microti disease in the prior art high technical issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antigen of Babesia vole bm1524 and its application
  • Antigen of Babesia vole bm1524 and its application
  • Antigen of Babesia vole bm1524 and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Collection of Babesia vole

[0042] Babesia microti selected from the Babesia microti provided by the Institute of Experimental Zoology, Chinese Academy of Medical Sciences PRA-99 TM Insect strain. Babesia microti was injected intraperitoneally, and BALB / c mice were inoculated. About 4 days later, the infection rate of protozoaemia reached 20%. Anticoagulant whole blood was collected. Leukocytes were separated from erythrocytes using Percoll density gradient centrifugation to remove leukocytes. The erythrocytes were lysed by adding erythrocyte lysate, and the precipitate was collected after centrifugation, which was determined to be Babesia worms by microscopic examination.

Embodiment 2

[0043] The separation and purification of embodiment 2 mRNA:

[0044] Babesia microti total RNA was extracted with TRIzol reagent from Invitrogen Company, and mRNA was isolated and purified from total RNA according to the instructions of the Oligitex mRNA Spin-Column Kit kit. And measure by agarose gel electrophoresis and ultraviolet analysis, detect the quality of mRNA (such as figure 1 shown).

Embodiment 3

[0045] Example 3 Transcriptome sequencing and analysis of Babesia microti:

[0046] The sequencing and analysis of the transcriptome were completed by Shanghai Ouyi Biomedical Technology Co., Ltd. The SMART cDNA library for sequencing was constructed using the SMART cDNA Library construction Kit kit from Clontech. Large-scale transcriptome sequencing was performed using a Roche 454 sequencer.

[0047] Preprocess the raw data of the transcriptome, remove the adapter sequence and primer sequence, and remove low-quality and short-length sequences. A total of 708,175 processed sequences were obtained.

[0048] Use Newbler software (version 2.6) to splice the above-mentioned processed sequences, set "Use duplicate reads", "Extend low depth overlaps", "Minimus read length" to 45bp, "Reads limited to one contig", "Single ACE file", The final assembly is 9377 Isotigs and 23088 Singlets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The present invention provides an isolated gene, the sequence of which is shown in SEQ ID NO:3. The present invention also provides a Babesia microti Bm1524 antigenic protein, which is encoded by the above isolated gene, and its amino acid sequence is shown in SEQ ID NO:4. The present invention also provides an antibody that specifically binds to the above-mentioned Babesia microti Bm1524 antigen protein. The present invention has further established a highly specific and sensitive diagnostic method for Babesia microti through the expression and purification of Babesia microti Bm1524 antigen, which can be applied to different aspects such as scientific research and prevention of Babesia microti; the present invention The vaccine has the effect of preventing Babesia vole infection. The kit and the colloidal gold immunochromatographic test strip of the invention can also be used to detect Babesia microti.

Description

technical field [0001] The invention belongs to the field of bioengineering, and relates to a parasite Babesia microti, specifically a Babesia microti Bm1524 antigen and application thereof. Background technique [0002] The first confirmed case of human babesiosis was reported in Yugoslavia in 1957. Subsequently, multiple cases of human babesiosis were reported successively in many European countries and the United States, and a small number of cases also appeared in Japan, mainland China and Taiwan in Asia, South Africa and Egypt in Africa. Babesia is a tick-borne zoonotic disease caused by Babesia parasitic on the red blood cells of vertebrates. At present, the Babesia that can cause human babesiosis have been identified, including a few species of Babesia (Babesiidae) such as Babesia microti and Babesia divergens. . [0003] Humans are usually infected through the bites of carrying ticks or clinical transfusion of blood donated by asymptomatic infected persons. The c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/30C07K14/44C07K16/20C12Q1/6893A61K39/018A61K39/395A61P33/02G01N33/569
Inventor 许学年周岩程娜徐斌胡薇
Owner STATION OF VIRUS PREVENTION & CONTROL CHINA DISEASES PREVENTION & CONTROL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products